eribulin mesylate,lenvatinib
eisai pharmaceutical
['sarcoma', 'eribulin']
lentatinib + eribulin in pts with lms and lps
- orr of 20%, dcr 90%
- impressive mpfs&gt;8 months many pts in 1st line randomized trial vs doxo in 1st line? or vs eribulin in 1+?
#sarcoma #asco22 
Medical Oncology Fellow @NIO_PIB, 
Visiting investigator @MSKCancerCenter, 
YOC Member @myESMO 
#Sarcoma #melanoma  
He/him ??????????